Prosecution Insights
Last updated: April 19, 2026

ZIM LABORATORIES LIMITED

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17922921 NOVEL EXTENDED RELEASE COMPOSITION OF TOFACITINIB, ITS DERIVATIVES AND SALTS LEE, WILLIAM Y 1623 Final Rejection Nov 02, 2022
17920200 NOVEL MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF TAMSULOSIN AND SOLIFENACIN BROWE, DAVID 1617 Non-Final OA Oct 20, 2022
17047063 COMPOSITION OF ACTIVE INGREDIENT LOADED EDIBLE INK AND METHODS OF MAKING SUITABLE SUBSTRATES FOR ACTIVE INGREDIENT PRINTING ON ORODISPERSIBLE FILMS MITCHELL, EDWIN COLEMAN 1619 Final Rejection Oct 12, 2020
15580684 MUCOSAL DELIVERY OF VITAMIN B12 HELM, CARALYNNE E 1615 Final Rejection Dec 07, 2017

Managing ZIM LABORATORIES LIMITED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month